Journal of Clinical Psychopharmacology

Papers
(The H4-Index of Journal of Clinical Psychopharmacology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia32
Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder32
Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior29
Persistent Barriers to the Use of Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia29
A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder28
Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers28
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs27
Citalopram and Cannabidiol26
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis23
Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder23
Comparison of Rapid Antidepressant and Antisuicidal Effects of Intramuscular Ketamine, Oral Ketamine, and Electroconvulsive Therapy in Patients With Major Depressive Disorder20
European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed20
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults20
Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia18
The Modernization of Clozapine17
A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression16
0.040235996246338